期刊文献+

98例原发性胃淋巴瘤的临床诊治分析 被引量:12

Clinical analysis of 98 cases of primary gastric lymphoma
原文传递
导出
摘要 目的探讨原发性胃淋巴瘤(PGL)的临床特点及诊治方法。方法回顾性分析中国医学科学院肿瘤医院1994年1月至2006年12月所收治的98例PGL患者的临床资料,总结其临床特点和治疗方式对患者生存期的影响。结果腹痛为本组病例最常见的临床症状,占51.0%。患者全部为Ⅰ、Ⅱ期肿瘤;PGL术前的确诊率为56.5%,1、3、5年总生存率分别为95.1%、86.0%和73.0%;Ⅰ期患者的5年生存率为89.5%,Ⅱ期患者为66.7%,两者差异有统计学意义(P=0.029)。手术治疗组患者5年生存率77.2%,非手术治疗组患者为75.0%,两者差异无统计学意义(P=0.794)。结论对于PGL,可首选全身化疗为主的治疗模式;在出现严重的消化道并发症、无明确活检病理诊断或化疗无效时可考虑手术治疗。 Objective To explore the clinical characteristics, diagnosis and treatment regimens for the primary gastric lymphoma(PGL). Methods The data of 98 PGL patients treated from January 1994 to December 2006 were collected and analyzed retrospectively. Results Abdominal pain was the common symptom of PGL. All the patients were at stage Ⅰ or stage Ⅱ, and the preoperative diagnosis rate was 56.5%. The overall 1-, 3- and 5-year survival rates were 95.1%, 86.0% and 73.0% respectively. The 5-year survival rates of stage Ⅰ and stage Ⅱ patients were 89.5% and 66.7% respectively, and the difference was significant. The 5-year survival rate of patients received operations was 77.2% and that without operation was 75.0%, the difference was not significant. Conclusions The therapy based on chemotherapy is preferred for the treatment of PGL. In the cases of serious gastrointestinal complications, indefinite pathological diagnosis or non-effective chemotherapy, operations should be considered.
出处 《中华胃肠外科杂志》 CAS 2008年第4期326-330,共5页 Chinese Journal of Gastrointestinal Surgery
关键词 胃肿瘤 淋巴瘤 预后 诊断 治疗 Stomach neoplasms Lymphoma Prognosis Diagnosis Treatment
  • 相关文献

参考文献16

  • 1Koch P, d′Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin's lymphoma: Anatomic and histological distribution, clinical features and survival data of 371 patients registered in the German muticenter study GIT NHL01/92. J Clin Oncol, 2001,19 : 3861-3873.
  • 2Dawson IM, Comes JS, Morson BC. Primary malignant lymphoid tumors of the intestinal tract, report of 37 cases with a study of factorsinfluencing prognosis. Br J Surg, 1961,49 : 80-89.
  • 3Carbone PP, Kaplan HS, Lukes R J, et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res, 1971,31 : 1860.
  • 4Shipp M, Harrington D, Anderson J, et al. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non- Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med, 1993,329 : 987-994.
  • 5National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer, 1982,49: 2112-2135.
  • 6Fischbach W, Dragasics B, Kolve Goebeler ME, et al. Primary gastric B-cell lymphoma: results of a prospective muhicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology, 2000, 119 : 1191-1202.
  • 7Maor MH, Velasquez WS, Fuller LM, et al. Stomach conservation in stages Ⅰ E and Ⅱ E gastric non-Hodgkin's lymphoma. J Clin Oncol, 1990,8:266-271.
  • 8Aviles A, Nambo M J, Neri N, et al. The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Ann Surg, 2004,240:44-50.
  • 9Willich NA, Reinartz G, Horst E J, et al. Operative and conservative management of primary gastric lymphoma: interim results of a German muhicenter study. Int J Radiat Oncol Biol Phys, 2000,46 : 895-901.
  • 10Koch P, Probst A, Berdel WE, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol, 2005,23 : 7050-7059.

二级参考文献18

  • 1Hermann R, Panahon AM, Barcos MP, et al. Gastrointestinal involvement in the non-Hodgkin's lymphoma [J]. Cancer,1980,46(1): 215-222.
  • 2Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas [J]. Cancer, 1972,29 (1): 252-260.
  • 3Koch P, d'Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin's lymphoma: Anatomic and histologic distribution.clinical features, and survival data of 371 patients registered in the German muticenter study GIT NHL01/92 [J]. J Clin Oncol, 2001,19(18): 3861-3873.
  • 4Rohatiner A, d'Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological staging of GI tract lymphomas [J]. Ann Oncol, 1994,5 (5): 397-400.
  • 5Taal BG, Burgers JMV, van Heerde P, et al. The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach [J]. Ann Onco, 1993,4(1): 839-846.
  • 6Gray GM, Rosenberg SA, Coope AD, et al. Lymphomas involving the gastrointestinal tract [J]. Gastroenterology, 1982,82(1): 143-152.
  • 7Aviles A, Nambo MJ, Neri N, et al. The role of surgery in primary gastric lmyphoma results of a central clinical trial [J].Ann Surg, 2004,240(1) :44-45.
  • 8Sueoka N, Inokushi K, Nishigaki H, et al. Genotype configuration in a case of primary gastric lymphoma with T-cell phenotype [J]. Cancer Genet Cytogenet, 1998,101 (2): 103-108.
  • 9Ferreri AJ, Cardio S, Ponzoni M, et al. Non-surgery treatment with primary chemotherapy,with and without radiation therapy of stage Ⅰ - Ⅱ high-grade lymphoma [J]. Leuk Lymphoma,1999,33(5-6) :531-541.
  • 10Dawson IM, Cornes JS , Morson BC. Primary malignant lymphoid tumors of the intestinal tract, report of 37 cases with a study of factors influencing prognosis [ J ] . Br J Surg, 1961 , 49(7) :80-89.

共引文献12

同被引文献134

引证文献12

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部